习惯性流产国际专利保胎技术International patent fetal protection technology for habitual abortion

　　习惯性流产保胎之免疫疗法——陈凤林经过几十年的科研和临床实践，研制成功了习惯性流产的免疫治疗新方法。治愈率95%以上， 该成果获得1997年北京市科技进步二等奖。2004年5月24日陈凤林院长做客健康之路系统阐述了习惯性流产的诊治技术。习惯性流产免疫治疗获得国内、国际共29个国家的专利技术，这标志着中国不孕不育治疗机构与国际水平接轨，达到并超过了世界先进水平。

　　After decades of research and clinical practice, Chen fenglin has successfully developed a new immunotherapy method for habitual abortion. The cure rate is more than 95%, and this achievement won the second prize of Beijing science and technology progress in 1997. On May 24, 2004, Chen fenglin, dean of the road to health system elaborated on the diagnosis and treatment of habitual abortion. Immunotherapy for habitual abortion has been patented in 29 countries at home and abroad, which marks that China's infertility treatment institutions are in line with the international standard and have reached and surpassed the world's advanced level.